Practice question

Answer the question and get instant feedback.

MediumEndocrinologyType 2 Diabetes Mellitusukmlamrcgp aktpaneprescribing safety assessment

A 72-year-old man is reviewed for his Type 2 Diabetes. His latest HbA1c is 50 mmol/mol. He is currently taking metformin 1g BD. He has a history of myocardial infarction 5 years ago and his eGFR is 55 mL/min/1.73m². According to NICE NG28, what is the most appropriate next pharmacological agent to add if lifestyle measures are optimised?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.